"Algernon Pharmaceuticals (CSE:AGN) receives $2M payment and applies for Nasdaq listing
Algernon Pharmaceuticals (AGN) has recently received a $2M cash payment from a refundable tax credit program for its clinical research work in Australia.
"Algernon (CSE:AGN) files meeting request with the MHRA for use of DMT in human stroke study
Algernon Pharmaceuticals (AGN) has filed a scientific advice meeting request with the United Kingdom Medicines and Healthcare Products Regulatory Agency (MHRA).